KENDELL SOGLIERO: Open Payments
NPI 1720654932 · SMITHFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,777 in 105 payments from 23 companies in 2025. Trend: 2023 $2,379 · 2024 $2,474 · 2025 $1,777
Food & beverage: $1,777
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $265 |
| Novo Nordisk Inc | 16 | $248 |
| PFIZER INC. | 10 | $172 |
| GlaxoSmithKline, LLC. | 12 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $154 |
| ABBVIE INC. | 12 | $139 |
| Phathom Pharmaceuticals, Inc. | 7 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Lilly USA, LLC | 4 | $65 |
Products named: BREZTRI, JARDIANCE, TRELEGY ELLIPTA, QULIPTA, VOQUEZNA, NURTEC ODT, CAPLYTA, SPRAVATO.
Industry payments across PA — which companies pay providers there.
